Sona Saira Ramasastry
Director/Board Member chez GLENMARK PHARMACEUTICALS LIMITED
Fortune : 941 583 $ au 31/03/2024
Profil
Sona Saira Ramasastry is the founder of Life Sciences Advisory LLC, which was founded in 2009.
She currently holds several positions as an independent director or member of the board of directors, including at Glenmark Pharmaceuticals Ltd., Vir Biotechnology, Inc., Mirum Pharmaceuticals, Inc., Pain Therapeutics, Inc., Elevian, Inc., DOT Therapeutics-2, Inc., and Day One Biopharmaceuticals, Inc. She is also a member of the Aspen Global Leadership Network and the European Prevention of Alzheimer's Dementia Consortium.
Ms. Ramasastry has held former positions as an independent director at Repros Therapeutics, Inc., Sangamo Therapeutics, Inc., Cassava Sciences, Inc., and 9 Meters Biopharma, Inc. She was also a financial analyst at Wasserstein Perella & Co., Inc. in 1997-1998.
Ms. Ramasastry received her undergraduate and graduate degrees from Stanford University and her graduate degree from the University of Cambridge.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2024 | 50 485 ( 0,06% ) | 834 012 $ | 31/03/2024 | |
VIR BIOTECHNOLOGY, INC.
0,01% | 01/06/2023 | 10 619 ( 0,01% ) | 107 570 $ | 31/03/2024 |
| 12/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Sona Saira Ramasastry
| Sociétés | Poste | Début |
|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | Director/Board Member | 01/04/2019 |
| VIR BIOTECHNOLOGY, INC. | Director/Board Member | 01/09/2019 |
| DAY ONE BIOPHARMACEUTICALS, INC. | Director/Board Member | 01/03/2021 |
| MIRUM PHARMACEUTICALS, INC. | Director/Board Member | 02/06/2022 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Director/Board Member | 12/04/2021 |
| European Prevention of Alzheimer's Dementia Consortium | Corporate Officer/Principal | - |
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Director/Board Member | - |
Pain Therapeutics, Inc.
 Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Director/Board Member | - |
| Aspen Global Leadership Network | Corporate Officer/Principal | - |
| ░░░░ ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Sona Saira Ramasastry
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Sona Saira Ramasastry
| Stanford University | Graduate Degree |
| University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| CASSAVA SCIENCES, INC. | Health Technology |
| GLENMARK PHARMACEUTICALS LIMITED | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| 9 METERS BIOPHARMA, INC. | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
American Liver Foundation
 American Liver Foundation Miscellaneous Commercial ServicesCommercial Services American Liver Foundation engages in facilitating, advocating and promoting education, support, and research for the prevention, treatment, and cure of liver disease. It educates patients, policymakers and the public and provides grants to early-career researchers to help find a cure for all liver diseases. The company was founded in 1976 and is headquartered in New York, NY. | Commercial Services |
| Wasserstein Perella & Co., Inc. | |
| Life Sciences Advisory LLC | |
| Aspen Global Leadership Network | |
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Pain Therapeutics, Inc.
Pain Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Pain Therapeutics, Inc. develops drugs. | Health Technology |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
| European Prevention of Alzheimer's Dementia Consortium | |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
